Skip to main content

Canadian authors Michael Ondaatje and Esi Edugyan have made the long list for this year’s Man Booker Prize in London.

Toronto-based Ondaatje made the list of 13 titles with Warlight, published by Jonathan Cape.

The honour comes just two weeks after he won the Golden Man Booker Prize, celebrating the 50th anniversary of the Man Booker Prize, for 1992’s The English Patient.

Story continues below advertisement

Victoria-based Edugyan made this year’s long list for Washington Black, published by Serpent’s Tail.

She was on the Booker short list in 2011 for Half-Blood Blues, which won the Scotiabank Giller Prize.

The short list of six books will be announced on Sept. 20 and the winner of the prize, worth about $86,000, will be announced Oct. 16.

This year’s Booker long list also includes six writers from the U.K., three from the U.S., and two from Ireland.

A panel of five judges chose the long list from 171 submissions — the highest number of titles put forward in the prize’s history.

In a statement, the judges called Ondaatje’s novel “wonderfully atmospheric” and “beautifully paced,” and Edugyan’s book “a dazzling exploration of race in the Atlantic world, which also manages to be a yarn and a chase story.”

The prize is open to writers of any nationality, writing in English and published in the U.K. and Ireland.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter